Sudarshana Sengupta's Colleagues at TCR2 Therapeutics
Sudarshana Sengupta's Contact Details
HQ
617-949-5200
617-949-5200
Location
Greater Boston
Greater Boston
Company
TCR2 Therapeutics
TCR2 Therapeutics
Sudarshana Sengupta's Company Details
TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.
Frequently Asked Questions about Sudarshana Sengupta
Sudarshana Sengupta currently works for TCR2 Therapeutics.
Sudarshana Sengupta's role at TCR2 Therapeutics is Associate Scientist.
Sudarshana Sengupta's email address is ***@tcr2.com. To view Sudarshana Sengupta's full email address, please signup to ConnectPlex.
Sudarshana Sengupta works in the BioTech/Drugs industry.
Sudarshana Sengupta's colleagues at TCR2 Therapeutics are Dana Gilmore, Urmi Patankar, Chris Manoogian, Stephanie Martin, Breckon Bauer, Richard Decker, Joshua Daniel and others.
Sudarshana Sengupta's phone number is 617-949-5200